Cleared Traditional

K250075 - Medtronic Stedi Extra Support Guidewire

K250075 is the FDA 510(k) clearance for Medtronic Stedi Extra Support Guidewire by Medtronic, Inc.. It is a Class 2 Cardiovascular device (product code DQX) cleared through the Traditional 510(k) pathway after a 154-day FDA review.

K250075 · Medtronic, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2025
Decision
154d
Days
Class 2
Risk

K250075 is an FDA 510(k) clearance for the Medtronic Stedi Extra Support Guidewire. Classified as Wire, Guide, Catheter (product code DQX), Class II - Special Controls.

Submitted by Medtronic, Inc. (Miinneapolis, US). The FDA issued a Cleared decision on June 13, 2025 after a review of 154 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtronic, Inc. devices

Submission Details

510(k) Number K250075 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 10, 2025
Decision Date June 13, 2025
Days to Decision 154 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d slower than avg
Panel avg: 125d · This submission: 154d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQX Wire, Guide, Catheter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQX Wire, Guide, Catheter

All 498
Devices cleared under the same product code (DQX) and FDA review panel - the closest regulatory comparables to K250075.
Amplatzer Guidewire
K250031 · Abbott Medical · Oct 2025
Splashwire Hydrophilic Guide Wire (MSWSTD35180J1O5)
K251181 · Merit Medical Ireland, Ltd. · Aug 2025
Hi-Torque Command 14 ST Guide Wire and Hi-Torque Command 14 MT Guide Wire
K250552 · Abbott Medical · Jul 2025
SION blue PLUS
K243733 · Asahi Intecc Co., Ltd. · Apr 2025
Crossloop
K241962 · Asahi Intecc Co., Ltd. · Mar 2025
CROSSLEAD 0.018inch
K242597 · Asahi Intecc Co., Ltd. · Mar 2025